Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Assets (2019 - 2025)

Historic Non-Current Assets for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to $470.9 million.

  • Legend Biotech's Non-Current Assets rose 2207.33% to $470.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.9 million, marking a year-over-year increase of 2207.33%. This contributed to the annual value of $386.2 million for FY2024, which is 1009.83% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Non-Current Assets is $470.9 million, which was up 2207.33% from $440.0 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Non-Current Assets registered a high of $470.9 million during Q3 2025, and its lowest value of $140179.0 during Q1 2021.
  • Over the past 5 years, Legend Biotech's median Non-Current Assets value was $330.5 million (recorded in 2023), while the average stood at $294.3 million.
  • As far as peak fluctuations go, Legend Biotech's Non-Current Assets soared by 15500686.21% in 2021, and later soared by 983.68% in 2025.
  • Over the past 5 years, Legend Biotech's Non-Current Assets (Quarter) stood at $169.6 million in 2021, then skyrocketed by 36.69% to $231.8 million in 2022, then surged by 51.31% to $350.8 million in 2023, then rose by 10.1% to $386.2 million in 2024, then rose by 21.93% to $470.9 million in 2025.
  • Its Non-Current Assets was $470.9 million in Q3 2025, compared to $440.0 million in Q2 2025 and $396.9 million in Q1 2025.